BDBM50327091 1-(5-tert-butylisoxazol-3-yl)-3-(2-chloro-4-(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)phenyl)urea::CHEMBL1253194::D3RKN_23

SMILES Cn1ccc2ncnc(Oc3ccc(NC(=O)Nc4cc(on4)C(C)(C)C)c(Cl)c3)c12

InChI Key InChIKey=VRFCECOEWLDCBE-UHFFFAOYSA-N

Data  2 IC50  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50327091   

TargetFibroblast growth factor receptor 1(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50327091(1-(5-tert-butylisoxazol-3-yl)-3-(2-chloro-4-(5-met...)
Affinity DataIC50: 220nMAssay Description:Inhibition of His-tagged human FGFR1 expressed in Sf9 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetVascular endothelial growth factor receptor 2(Human)
Takeda Pharmaceutical

Curated by ChEMBL
LigandPNGBDBM50327091(1-(5-tert-butylisoxazol-3-yl)-3-(2-chloro-4-(5-met...)
Affinity DataIC50: 8.90nMAssay Description:Inhibition of His-tagged human VEGFR2 expressed in Sf9 cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/12/2011
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
D3R/Abbott

LigandPNGBDBM50327091(1-(5-tert-butylisoxazol-3-yl)-3-(2-chloro-4-(5-met...)
Affinity DataKd:  1.00E+4nMAssay Description:D3R2022More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2023
Entry Details
D3R

LigandPNGBDBM50327091(1-(5-tert-butylisoxazol-3-yl)-3-(2-chloro-4-(5-met...)
Affinity DataKd:  370nMAssay Description:D3R2023More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/19/2023
Entry Details
D3R